Concepedia

Thomas Bauknecht

TB

50

Publications

2.6K

Citations

28

H-Index

1976

Active since

Affiliations

University of Freiburg(Current)

Universitäts Frauenklinik

Eli Lilly (Germany)

Eli Lilly (United States)

Charité - Universitätsmedizin Berlin

Thomas Bauknecht is an author at University of Freiburg specializing in medicine, obstetrics, and ovarian cancer.

Top concepts

Publications per year

1976–2017

50

Publications

50

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trial

Willemien J. van Driel, Maaike E. Ressing, Gemma G. Kenter et al. · European Journal of Cancer · 1999 · 230 citations

, , +12

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

Ivo Meinhold‐Heerlein, Dirk Bauerschlag, Felix Hilpert et al. · Oncogene · 2004 · 205 citations

, , +9

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

Andreas M. Kaufmann, Peter L. Stern, Elaine M. Rankin et al. · PubMed · 2002 · 204 citations

Detection of T Helper Responses, But Not of Human Papillomavirus-Specific Cytotoxic T Lymphocyte Responses, After Peptide Vaccination of Patients With Cervical Carcinoma

Maaike E. Ressing, Willemien J. van Driel, Remco M.P. Brandt et al. · Journal of Immunotherapy · 2000 · 172 citations

Differential chromatid staining by in vivo treatment as a mutagenicity test system

Walther Vogel, Thomas Bauknecht · Nature · 1976 · 150 citations

, , +8

Rows per page

1–5 of 50